NeuroSense Therapeutics Ltd. (NRSN) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

NeuroSense Therapeutics Ltd. (NRSN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $22.1M, listed on NASDAQ, employing roughly 17 people, carrying a beta of 1.58 to the broader market. NeuroSense Therapeutics Ltd. Led by Alon Ben-Noon, public since 2021-12-09.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for NRSN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →